BNT162b2 COVID-19 vaccine

URI: https://gptkb.org/entity/BNT162b2_COVID-19_vaccine

GPTKB entity

Statements (51)

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:age	6 months and older
gptkbp:approvedBy	gptkb:World_Health_Organization gptkb:European_Medicines_Agency gptkb:U.S._Food_and_Drug_Administration
gptkbp:boosterRecommended	yes
gptkbp:boosters	yes
gptkbp:brand	gptkb:Comirnaty
gptkbp:clinicalTrialPhase	July 2020 - November 2020
gptkbp:contains	gptkb:plastic sodium chloride potassium chloride sucrose cholesterol lipid nanoparticles water for injection dibasic sodium phosphate dihydrate monobasic potassium phosphate nucleoside-modified mRNA
gptkbp:containsAdjuvant	no
gptkbp:containsPreservatives	no
gptkbp:developedBy	gptkb:Pfizer gptkb:BioNTech
gptkbp:distribution	global
gptkbp:efficacyAgainstOriginalStrain	~95%
gptkbp:emergencyServices	December 2020
gptkbp:emergencyUseCountries	over 100 countries
gptkbp:firstAdministered	December 2020
gptkbp:form	two doses, 3 weeks apart
gptkbp:fullApprovalDate	August 2021
https://www.w3.org/2000/01/rdf-schema#label	BNT162b2 COVID-19 vaccine
gptkbp:indication	prevention of COVID-19
gptkbp:patent	gptkb:Pfizer gptkb:BioNTech
gptkbp:pregnancyCategory	consult healthcare provider
gptkbp:rareAdverseEvent	anaphylaxis myocarditis
gptkbp:routeOfAdministration	intramuscular injection
gptkbp:sideEffect	fever fatigue headache muscle pain chills injection site pain
gptkbp:storage	-70°C
gptkbp:target	gptkb:SARS-CoV-2_spike_protein
gptkbp:technology	gptkb:gene
gptkbp:variantAdaptedFormulations	Omicron-adapted
gptkbp:WHOEmergencyUseListing	December 2020
gptkbp:bfsParent	gptkb:BioNTech_RNA_Pharmaceuticals_GmbH
gptkbp:bfsLayer	6